Nancy Hilda Joseph

Nancy Hilda

Scientist (Immunology)

ICMR-National Institute for Research in Tuberculosis (ICMR-NIRT), India

Email: nancyhilda.j@nirt.res.in

 

 

 

 

VALIDATE Role:

Network Associate

 

Biography:

Since completing her doctoral studies in neutrophil responses during tuberculosis in 2016, Nancy has focused on TB vaccine immunology. Her 13 years of research span neutrophil and monocyte responses to Mycobacterium tuberculosis, and T cell responses to TB vaccines. Currently, Nancy is working on a phase III trial in India to evaluate the efficacy and safety of VPM1002 and Immuvac vaccines against TB. Dr Hilda attended the International Vaccinology Course in Seoul and has also researched follicular T helper cell responses during HIV-2 infection. She is now involved in a vaccine design project to prevent HIV-1 infection and is an associate member of the VALIDATE network.